KLEO PHARMACEUTICALS

Live / Applied — Statement of use — registration review complete (as of 30 Oct 2026)

What this means for you

Not registered yet, but its 16 Dec 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97981646
Mark type
Word mark
Filed
16 Dec 2021
Published for opposition
23 Jan 2024
Attorney of record
Monica Riva Talley

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical products for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders; none of the foregoing to include nutritional supplements, personal lubricants, personal sexual lubricants, vitamin supplement patches, vitamins, or gels for use as personal lubricant

Owner

Prosecution history

  • 30 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 30 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 30 Oct 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 21 Sept 2026 — USE AMENDMENT FILED
  • 30 Oct 2026 — DIVISIONAL PROCESSING COMPLETE
  • 21 Sept 2026 — DIVISIONAL REQUEST RECEIVED
  • 27 Oct 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 21 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
  • 21 Sept 2026 — TEAS REQUEST TO DIVIDE RECEIVED
  • 27 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 27 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 27 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 10 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 10 Mar 2026 — SOU EXTENSION 4 GRANTED
  • 10 Mar 2026 — SOU EXTENSION 4 FILED

View this trademark record on Rightsy